Mainstream

Ptc Outlines Ai Driven Product Advancements And Anticipates 9% 10% Arr Growth In 2025

PTC outlines AI-driven product advancements and anticipates 9%-10% ARR growth in 2025

PTC outlines AI-driven product advancements and anticipates 9%-10% ARR growth in 2025

Post ContentptcRead More

You might also be interested in reading Regeneron nabs FDA label expansion for Ultragenyx-partnered cholesterol drug.

February 6, 2025
In Mainstream